Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0OB3 stock hub

LON/0OB3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0OB3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

393.2M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0OB3

In the news

Latest news · LON/0OB3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-80.2

P25 -54.2P50 2.1P75 13.7

ROIC-40.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0OB3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

EUR

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	674
Employees Change	-39%
Employees Change Percent	-5.47
Enterprise value	EUR 477.5M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	FR0004056851
Last refreshed	2026-05-10
Market cap	EUR 393.2M
Price	EUR 2.42
Price currency	EUR
Rev Per Employee	226,064.95x
Sector	Healthcare
Sic	2836
Symbol	lon/0OB3
Website	https://valneva.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-25.56%
EV Earnings	-4.75x
EV/FCF	-9.55x
EV/Sales	3.16x
FCF yield	-12.72%
P/B ratio	4.24x
P/S ratio	2.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-46.74%
EBITDA Margin	-37.04%
Gross margin	-10.18%
Gross Profit	EUR -15.5M
Net Income	EUR -100.5M
Net Income Growth Years	0%
Pretax Margin	-65.34%
Profit Margin	-65.95%
Profit Per Employee	EUR -149,096
ROA	-11.35
Roa5y	-7.04
ROCE	-26.72
ROE	-80.16
Roe5y	-55.79
ROIC	-40.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.11%
Cagr15y	-6.43%
Cagr1y	-17.2%
Cagr3y	-24.77%
Cagr5y	-27.77%
EPS Growth Years	0
Revenue Growth	3x
Revenue Growth Q	-9.92x
Revenue Growth Years	2x
Revenue Growth3 Y	-21.52x
Revenue Growth5 Y	9.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.39
Assets	EUR 347.9M
Cash	EUR 95.7M
Current Assets	EUR 192.5M
Current Liabilities	EUR 80.7M
Debt	EUR 180.8M
Debt Equity	EUR 1.95
Debt FCF	EUR -3.62
Equity	EUR 92.6M
Interest Coverage	-1.95
Liabilities	EUR 255.3M
Long Term Assets	EUR 155.4M
Long Term Liabilities	EUR 174.6M
Net Cash	EUR -85.1M
Net Cash By Market Cap	EUR -21.66
Net Debt Equity	EUR 0.92
Tangible Book Value	EUR 74M
Tangible Book Value Per Share	EUR 0.43
WACC	12.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.38
Inventory Turnover	3.7
Net Working Capital	EUR 35.1M
Quick ratio	1.47
Working Capital	EUR 112.7M
Working Capital Turnover	EUR 0.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-27.12%
1Y total return	-17.19%
200-day SMA	3.88
3Y total return	-57.44%
50-day SMA	3.34
50-day SMA vs 200-day SMA	50under200
5Y total return	-80.33%
All Time High	29.54
All Time High Change	-91.8%
All Time High Date	2021-11-30
All Time Low	1.72
All Time Low Change	41%
All Time Low Date	2024-12-17
ATR	0.16
Beta	1.33
Ch YTD	-34.67
High	2.48
High52	5.42
High52 Date	2025-08-18
High52ch	-55.33%
Low	2.38
Low52	2.13
Low52 Date	2026-05-04
Low52ch	13.5%
Ma50ch	-27.56%
Price vs 200-day SMA	-37.67%
RSI	39.48
RSI Monthly	42.27
RSI Weekly	34.51
Sharpe ratio	0.14x
Sortino ratio	0.25
Total Return	-15.42%
Tr YTD	-34.68
Tr15y	-63.1%
Tr1m	-5.28%
Tr1w	11.37%
Tr3m	-38.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -71.2M
Operating margin	-46.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	156,858,086%
Net Borrowing	52,766.9
Shares Insiders	1.43%
Shares Institutions	20.12%
Shares Qo Q	-5.34%
Shares Yo Y	15.42%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -59.5M
Average Volume	60,671.55x
Bv Per Share	0.53
CAPEX	EUR -3.9M
Ch10y	-27.12
Ch15y	-70.26
Ch1m	-5.28
Ch1w	11.36
Ch1y	-17.18
Ch3m	-38.82
Ch3y	-57.44
Ch5y	-80.33
Ch6m	-34.92
Change	1.49%
Change From Open	-0.66
Close	2.39
Days Gap	2.18
Depreciation Amortization	14,642,391.4
Dollar Volume	54,605
Earnings Date	2026-05-13
EBIT	EUR -71.2M
EBITDA	EUR -56.4M
EPS	EUR -0.6
F Score	3
FCF	EUR -50M
FCF EV Yield	-10.47x
Financing CF	-541,744
Fiscal Year End	December
Founded	1,998
Income Tax	EUR 936,056
Investing CF	-1,490,885
Is Primary Listing	0
Last Earnings Date	2026-03-18
Last Report Date	2025-12-31
Ma150	3.83
Ma150ch	-36.79%
Ma20	2.46
Ma20ch	-1.67%
Net CF	-51,139,372
Next Earnings Date	2026-05-13
Open	2.44
Position In Range	42.17
Ppne	119,402,053.9
Price Date	2026-05-08
Ptbv Ratio	5.32
Relative Volume	0.38x
Revenue	152,367,779x
SBC By Revenue	6.26x
Share Based Comp	9,544,632
Tax By Revenue	0.61x
Tr6m	-34.92%
Volume	22,555
Z Score	-1.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0OB3 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0OB3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0OB3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.1%

Share of float held by funds and institutions

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+15.4%

Negative means the company is buying back shares.

Technical

LON/0OB3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.5

Neutral momentum band

Price vs 200-day MA

-37.7%

50/200-day relationship not available

Beta (5Y)

1.33

More volatile than the market

Sharpe ratio

0.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0OB3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0OB3 stock rating?

lon/0OB3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0OB3 analysis?

The full report lives at /stocks/lon/0OB3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0OB3?

The latest report frames lon/0OB3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0OB3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.